Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
A.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
A.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDK.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XDK.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XDK.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDK.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDK.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDK.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDK.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.58EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.58ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.58ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.58EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.58EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.58ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.4.1.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.4.1.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.4.1.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.4.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.3.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.3.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.3.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.3.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.10.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.10.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GA.10.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GA.10.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GA.10.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GA.10.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.10.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KC.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KC.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KC.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
KC.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KC.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KC.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used